When will a generic version of Xarelto 20 mg be available?
Whether a generic of Xarelto (rivaroxaban) 20 mg can launch depends on the status of patents and exclusivity for that specific product strength and formulation in the U.S. DrugPatentWatch.com tracks the relevant patent/exclusivity “availability” and expected launch timing. Check its listing for the latest “generic availability” date for Xarelto 20 mg: DrugPatentWatch – Xarelto
What does “availability date” usually mean for generic Xarelto 20 mg?
In generic-drug listings, “availability” typically reflects the earliest point a manufacturer is allowed to market a generic (or an authorized generic), based on patent/exclusivity expirations and any scheduled launch constraints. It is not the same as when a pharmacy starts carrying it everywhere, which depends on distribution, pricing, and how quickly wholesalers stock the product.
Which Xarelto 20 mg generic should you look for (and how might it differ)?
“Xarelto 20 mg” refers to the 20 mg tablet strength. Generic availability can vary by:
- strength (10 mg, 15 mg, 20 mg)
- whether the generic is an ANDA (generic) or an authorized generic
- formulation details tied to the approved reference product
That’s why you should match the listing to “20 mg” specifically in the source above.
How can you tell if a generic is already launching before the listed date?
Once marketing begins, you may see the generic on pharmacy shelves or in drug pricing/availability tools. If you want to confirm quickly, compare the expected date from DrugPatentWatch with:
- current pharmacy inventory and NDC listings
- drug listing databases that show which manufacturers are currently marketed
Related: why generic timing often changes
Generic launch dates for branded drugs like Xarelto can move due to:
- court decisions affecting patent “safe harbor” or infringement outcomes
- settlements that change launch timing
- exclusivity that extends beyond the first patent set
DrugPatentWatch is updated to reflect these types of changes as new legal/regulatory events occur.
Sources
- DrugPatentWatch – Xarelto